Using advanced imaging technology to develop new treatments for diseases
Official title: MicroSPECT/CT to aid the development of theranostics
Funded at Case Western Reserve University · NIH-10852342 · Data updated 2026-11-12
This study is using a new advanced scanner to help researchers better understand diseases and develop new treatments, especially for infections and immune-related conditions, which could eventually lead to better options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project start | August 15, 2024 |
| Project end | August 14, 2025 |
| Funding year | 2024 |
| Award (this year) | $827,060 |
| NIH project number | 1S10OD036247-01 |
| Project ID | NIH-10852342 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include those with conditions that are being targeted by the novel therapies developed through this imaging technology.
✕Less likely to help
Patients with conditions unrelated to the diseases being studied or those who do not meet the criteria for the specific therapeutic developments may not receive benefits from this research.
What this research studies
This research involves the acquisition of a new preclinical SPECT-CT scanner at Case Western Reserve University to enhance imaging capabilities for various disease models. The scanner will support a wide range of research, including the development of novel theranostic agents and therapeutic strategies, particularly in the fields of anti-viral therapy and immunotherapy. By enabling detailed imaging of larger animals and infectious disease models, this project aims to facilitate significant advancements in basic science research and therapeutic development. Patients may benefit indirectly through the development of new treatments and therapies that arise from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative treatments for various diseases, improving patient outcomes.
How similar studies have gone: Other research has shown success with similar imaging technologies in advancing therapeutic development, indicating a promising potential for this approach.
Where this research is happening
-
Case Western Reserve University
Cleveland, United States Active
Researchers
- Principal investigator: Lee, Zhenghong — Case Western Reserve University
- Study coordinator: Lee, Zhenghong
Related research
Other NIH-funded projects on the same topics.
-
Estrogen signaling and how the intestinal lining protects against injury
A study at Case Western Reserve University looks at how estrogen receptors in the gut lining help protect against intestinal injury and inflammatory bowel disease.
-
Diabetes: Long-term effects of intensive glucose control on complications
A long-term study follows adults with type 1 diabetes to see how keeping blood sugar close to normal affects eye, kidney, nerve, heart, and quality of life outcomes over many years.
-
Epidemiology of Diabetes Interventions and Complications (EDIC) Study follow-up
This long-term study follows adults with type 1 diabetes to see how early intensive glucose control affects complications and quality of life over many years.
-
Role of THAP1 in brain cell support cells shaping brain development
Aims to understand how the THAP1 protein in oligodendrocyte lineage cells helps shape the brain’s environment and myelination during development, which may relate to a movement disorder called DYT6 dystonia.
-
New human monoclonal antibodies to stop malaria caused by Plasmodium vivax
A researcher team is developing human monoclonal antibodies to prevent and treat malaria from Plasmodium vivax, with a plan to test promising antibodies in primates and prepare for human trials.
-
PopCASE: A user-friendly tool to link cancer data for communities and researchers
Aimed at improving population cancer research, PopCASE helps connect patient cancer data with community information to inform better care and outreach.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.